www.fdanews.com/articles/157419-eisai-receives-positive-opinion-from-ema-s-chmp-on-use-of-antiepileptic-agent-zonegran-in-pediatric-patients
Eisai Receives Positive Opinion From EMA's CHMP on Use of Antiepileptic Agent Zonegran in Pediatric Patients
July 29, 2013
The European Medicines Agency’s Committee for Medicinal Products for Human Use granted Eisai a license extension for pediatric Zonegran.
Eisai
Eisai